See the DrugPatentWatch profile for cosentyx

Adjusting the dosage of Cosentyx, a medication used to treat several conditions including plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis, can be risky without doctor input due to several factors.

Firstly, Cosentyx has a specific dosage regimen recommended by the manufacturer and healthcare professionals, based on clinical trials and patient response. Altering this dosage without medical advice can lead to suboptimal treatment outcomes or potential side effects [1].

Secondly, Cosentyx's active ingredient, secukinumab, works by inhibiting a specific protein in the body's immune response. Changing the dosage can disrupt this delicate balance, potentially leading to increased risk of infections or other adverse reactions [1].

Thirdly, Cosentyx's patent protection status can also play a role in dosage adjustment risks. Once a drug's patent expires, generic versions become available, which can lead to changes in the drug's formulation or administration. Without a doctor's guidance, patients may not fully understand these changes and their implications, potentially leading to dosage errors or other issues [2].

In conclusion, adjusting Cosentyx's dosage without a doctor's input can be risky due to the potential for suboptimal treatment outcomes, increased risk of side effects, and potential misunderstanding of changes related to patent status.

Sources:
[1] "Cosentyx (secukinumab) Injection, for Subcutaneous Use." Novartis Pharmaceuticals Corporation, 2021, https://www.pharma.us.novartis.com/sites/www.pharma.us.novartis.com/files/cosentyx.pdf.
[2] "Secukinumab (Cosentyx)." DrugPatentWatch, 2021, https://drugpatentwatch.com/drugs/secukinumab.